Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Daniel P. Judge, MD
Healthcare Professional Director
Cardiovascular Genetics Program
Medical University of South Carolina
30 Courtenay Drive, MSC 592
Charleston, South Carolina, United States
Dr. Daniel Judge is a cardiology specialist in Charleston, SC and has been practicing for 19 years. He received his medical degree at University of Pennsylvania, and did his post-graduate training in internal medicine, cardiology and advanced heart failure at Johns Hopkins. He was a cardiologist at Johns Hopkins until September 2017, when he moved to Charleston.
As a cardiologist and translational scientist, his research is focused on monogenic forms of cardiovascular disease, with particular emphasis on heart failure. He is the Director of the Medical University of South Carolina (MUSC) Cardiovascular Genetics program and the Fellowship Director for Cardiovascular Disease at MUSC. His post-doctoral research at Johns Hopkins University was focused on the molecular pathogenesis and translational treatments for Marfan syndrome and other inherited aortic diseases. For the past fifteen years, his research program focused on the genetic basis and pathogenesis of inherited heart disease, with translational research trials investigating novel therapies targeting key factors involved with disease pathogenesis.
His research interests include inherited cardiovascular diseases, amyloid, familial mitral valve disease, arrhythmogenic right ventricular dysplasia (ARVD) – genetics and pathogenesis, muscular dystrophies.
Representative Publications:
myBinderRelated Content
-
Features of Atrial Fibrillation in Wild‐Type Transthyretin Cardiac Amyloidosis: A Systematic Review and Clinical E...Aims: Wild-type transthyretin (ATTRwt) ...
-
Jack Khouri, MDJack Khouri is a Hematologist/Oncologist...
-
Morie A. Gertz, MDMorie A. Gertz is a graduate from Northw...
-
U.S. FDA Approves VYNDAQEL® and VYNDAMAX™ for Use in Patients with Transthyretin Amyloid Cardiomyopathy, a Rare a...Pfizer Inc. announced today that the U.S...
-
ESC: Tafamidis Cuts Deaths, Admissions in TTR Cardiac AmyloidosisTreatment with the investigational drug ...
-
S. Vincent Rajkumar, MDS. Vincent Rajkumar is a Hematologist/In...
-
Kevin R. Anderson, MDDr. Kevin R. Anderson received his medic...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
